Veloxis Pharmaceuticals A/S - Company & Market Research Reports

Veloxis Pharmaceuticals is a commercial-stage specialty pharmaceutical company that operates in Europe and the United States. Veloxis’ products include tacrolimus extended-release tablets called Envarsus XR and MeltDose, which is designed to enhance the absorption and bioavailability of select orally administered drugs. The company was formerly known as LifeCycle Pharma A/S and changed its name to Veloxis Pharmaceuticals A/S in July 2011. Veloxis is based in Copenhagen, Denmark.